Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study of Prophylactic Ibuprofen Versus Placebo on Pain Relief and Success Rates of Medical Abortion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Good general health~* Pregnancy of up to 7 weeks gestation.~* Approval from the Ministry of Health committee for termination of pregnancy after an intrauterine pregnancy was demonstrated by an ultrasound exam.~* Subjects that provided informed consent and agree to comply with all study procedures.~Exclusion Criteria:~* Known allergy to mifepristone, misoprostol, paracetamol or NSAIDs.~* Severe anemia.~* Drug or alcohol abuse~* Known abnormal liver function (liver function tests greater than 1.5 times upper range of normal).~* Known abnormal renal function (serum creatinine \> 1.5 mg/dl).~* Abnormal blood tests~* Exclusionary health problems contraindicating mifepristone included adrenal disease; sickle cell anemia; severe liver, respiratory, or renal disease; and blood clotting defect.~* Chronic disease~* Patient is participating currently in another clinical trial

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- ibuprofen (Type: EXPERIMENTAL): the group will receive 2 tablets of ibuprofen 400 mg at the time of misoprostol administration. The information about the effect of the analgesics on the pain, and on the course of medical abortion, will be prospectively gathered from questionnaires completed by the study participants
- placebo (Type: NO_INTERVENTION): this group will receive 2 placebo tablets together with the misoprostol

Based on this trial design, predict the completion outcome and termination type (if applicable).